Clinical Trial Update: Evaluation of the Safety and Efficacy of a Single Dose of SKY0402 in Subjects Undergoing Augmentation Mammoplasty [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a single-dose SKY0402 for safety and efficacy in patients undergoing augmentation mammoplasty has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• SKY0402

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED | Results posted: 2013-08-06